CVC Capital Partners plc (VIE:CVC)
Austria · Delayed Price · Currency is EUR | Market Cap | 16.42B -7.1% |
| Revenue (ttm) | 2.01B +13.5% |
| Net Income | 966.11M +28.0% |
| EPS | 0.77 +57.8% |
| Shares Out | n/a |
| PE Ratio | 16.99 |
| Forward PE | 17.45 |
| Dividend | 0.50 (3.20%) |
| Ex-Dividend Date | Aug 20, 2026 |
| Volume | 658 |
| Open | 15.72 |
| Previous Close | 15.96 |
| Day's Range | 15.66 - 15.80 |
| 52-Week Range | 10.58 - 17.77 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About CVC Capital Partners
CVC Capital Partners plc is a private equity and venture capital firm specializing in middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature, recapitalizations, strip sales, and spinouts. The firm makes investments in medium to large sized companies. It seeks to invest in fintech, healthcare, industrial, Education, telecommunications, information technology, electronics, biotechnology, medical, energy, chemistry, new materials, industrial automatisms, tech-enabled businesses such as hu... [Read more]
Financial Performance
In 2025, CVC Capital Partners's revenue was 1.85 billion, an increase of 18.53% compared to the previous year's 1.56 billion. Earnings were 1.18 billion, an increase of 425.14%.
Financial StatementsNews
CVC Capital Partners price target raised to EUR 18 from EUR 16.20 at Citi
Citi analyst Nicholas Herman raised the firm’s price target on CVC Capital Partners (CVCCF) to EUR 18 from EUR 16.20 and keeps a Buy rating on the shares. Published first…
CVC Capital Partners Earnings Call Transcript: H1 2026
Record realizations and strong fundraising drove double-digit growth in AUM, revenues, and earnings in H1 2026. Expansion in credit, secondaries, and infrastructure, plus the Marathon acquisition, position the firm for continued growth and market share gains.
CVC Capital Partners Quarterly report: H1 2026
CVC Capital Partners has published its H1 2026 quarterly earnings report on July 30, 2026.
CVC Capital Partners Slides: H1 2026
CVC Capital Partners has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 30, 2026.
Italy's Recordati says board finds CVC, GBL offer 'fair' as independent directors dissent
Recordati said on Wednesday that a majority of its board has deemed as "fair" an offer by private equity firm CVC Capital Partners and Belgian investment group Groupe Bruxelles Lambert to take the I...
CVC Capital Partners to Buy Ingredients Business Irca From Advent
Irca creates more than 7,000 products and serves customers in more than 100 countries and CVC said it would support the next phase of the company's growth.
CVC Capital Partners price target raised to EUR 16.20 from EUR 16 at Citi
Citi raised the firm’s price target on CVC Capital Partners (CVCCF) to EUR 16.20 from EUR 16 and keeps a Buy rating on the shares.
CVC, Groupe Bruxelles Lambert Make $12.5 Billion Bid to Take Recordati Private
The consortium said the offer is aimed at delisting Recordati from Euronext Milan and supporting the drugmaker's expansion in rare diseases.
CVC, GBL launch 10.7 bln euro full takeover offer for Italy's Recordati
Private equity firm CVC Capital Partners and Belgian investment group GBL said on Friday they had launched a 10.7 billion euro ($12.43 billion) full voluntary cash bid on Italian pharmaceutical gro...
CVC Capital Partners Transcript: AGM 2026
The meeting highlighted strong financial growth, leadership transition, and strategic expansion in private wealth and insurance channels. All resolutions, including a final dividend and governance measures, were approved by shareholders.
CVC Capital Partners Posts Rise in Fee-Paying Client Assets
The buyout firm closed the first quarter with fee-paying assets under management of $176.47 billion, up from $173.69 billion at the end of the previous quarter.
CVC Capital Partners Earnings release: Q1 2026
CVC Capital Partners released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
CVC considering EUR 9B bid for Nexi, FT reports
CVC Capital Partners (CVCCF) is considering a EUR 9B bid to take Nexi (NEXXY) private after a sharp decline in its share price, though any deal would depend on support…
CVC Capital Partners price target lowered to EUR 16 from EUR 17.50 at Citi
Citi analyst Nicholas Herman lowered the firm’s price target on CVC Capital Partners (CVCCF) to EUR 16 from EUR 17.50 and keeps a Buy rating on the shares. The firm…
CVC Capital Partners price target lowered to EUR 17.50 from EUR 21.10 at Citi
Citi lowered the firm’s price target on CVC Capital Partners (CVCCF) to EUR 17.50 from EUR 21.10 and keeps a Buy rating on the shares.
CVC Capital Partners Shares Slip as Performance-Related Earnings Guidance Disappoints
The guidance overshadowed better-than-expected results for 2025, with the firm posting a 67% increase in realizations.
CVC Capital Partners Earnings Call Transcript: H2 2025
Fee-paying AUM grew to EUR 148 billion in 2025, driven by strong inflows and record realizations, with credit, secondaries, and infrastructure now over half of AUM. Management fees and EBITDA rose, and the outlook targets 10%+ annual AUM growth to EUR 200 billion by 2028.
CVC Capital Partners Earnings release: H2 2025
CVC Capital Partners released its H2 2025 earnings on March 11, 2026, summarizing the period's financial results.
CVC Capital Partners Annual report: H2 2025
CVC Capital Partners has published its H2 2025 annual report on March 11, 2026.
CVC Capital Partners Slides: H2 2025
CVC Capital Partners has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 11, 2026.
CVC earnings guidance disappoints, shares fall
Private equity firm CVC Capital Partners announced on Wednesday a lower near-term performance-related earnings (PRE) outlook than expected, sending its shares down.
CVC Capital Partners Earnings release: Q4 2025
CVC Capital Partners released its Q4 2025 earnings on February 12, 2026, summarizing the period's financial results.
DSM-Firmenich to Sell Animal Nutrition Unit to CVC in $2.6 Billion Deal
The sale to CVC Capital Partners marks the final step in its plan to fully focus on human nutrition, health and beauty.
DSM-Firmenich to sell animal health business to CVC Capital
Chemicals company DSM-Firmenich has agreed to sell its Animal Nutrition & Health business to CVC Capital for an enterprise value of around 2.2 billion euros ($2.6 billion), it said on Monday.
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners
Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovat...